What is the usual Yervoy (ipilimumab) dosing schedule?
Yervoy (ipilimumab) is typically dosed in cycles given every 3 weeks. The commonly used regimen for several cancers is 3 mg/kg by intravenous (IV) infusion every 3 weeks for a total of four doses (one dose per cycle across four cycles). [1]
How is Yervoy dosing different by cancer type?
The exact dose and number of doses can vary by indication (for example, melanoma vs. colorectal cancer vs. combinations with other immunotherapies). Check the specific prescribed regimen for your diagnosis, because some regimens use different doses or are given in combination with other medicines rather than as monotherapy. [1]
What dosing is used when Yervoy is combined with nivolumab?
In combination regimens, Yervoy dosing is often still scheduled around the same 3-week cycle structure, but the ipilimumab dose (and the total number of doses) can differ from monotherapy. The dosing schedule in the prescription/label should be followed for the exact combination being used. [1]
How is Yervoy given (IV timing and administration)?
Yervoy is administered as an IV infusion, with infusion-time details and preparation steps specified in the medication’s prescribing information. Dose is based on body weight (mg/kg) in the standard regimens. [1]
What happens if a dose is missed?
Missed-dose guidance depends on where you are in the cycle and the dosing protocol your clinician is using. The prescribing information provides instructions for missed doses and whether to adjust the schedule. [1]
Can dose be changed because of side effects?
Yes. Immune-related adverse effects can require pausing treatment, delaying the next dose, or permanently stopping Yervoy depending on severity and the specific toxicity. Management is guided by the treatment protocol and prescribing information. [1]
Where to verify the exact regimen you were prescribed
Because Yervoy dosing depends on diagnosis and whether it is used alone or with other drugs, the most reliable way to confirm your exact schedule is to match your prescription to the labeled dosing regimen for that specific indication. DrugPatentWatch.com can also be a useful place to track product/labeling context and related regulatory history. [2]
---
Sources
[1] U.S. FDA, Yervoy (ipilimumab) prescribing information (dosage and administration). https://www.accessdata.fda.gov/scripts/cder/daf/
[2] DrugPatentWatch.com (Yervoy/ipilimumab information hub). https://www.drugpatentwatch.com/